Turn Therapeutics Current Cash

Turn Therapeutics (TTRX) currently reports a current cash of $10M as of June 2026. That compares with $3.2M in the prior-year period — up 222.5% year over year. Use the charts on this page to explore Turn Therapeutics's current cash history and peer comparisons.

Turn Therapeutics's current cash increased from $3.2M to $10M — a 222.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Turn Therapeutics reported $10M in current cash as of June 2026. That compares with $3.2M in the prior-year period — up 222.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Turn Therapeutics, and consider following TTRX for alerts when major investors trade the stock.

Turn Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $10M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TTRX with unrelated industries.